These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 16632216)

  • 1. Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination.
    Thompson JF; Scolyer RA; Uren RF
    Surg Oncol Clin N Am; 2006 Apr; 15(2):301-18. PubMed ID: 16632216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is completion lymphadenectomy after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary?
    Elias N; Tanabe KK; Sober AJ; Gadd MA; Mihm MC; Goodspeed B; Cosimi AB
    Arch Surg; 2004 Apr; 139(4):400-4; discussion 404-5. PubMed ID: 15078708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel node mapping for melanoma: results of trials and current applications.
    Thompson JF; Shaw HM
    Surg Oncol Clin N Am; 2007 Jan; 16(1):35-54. PubMed ID: 17336235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma.
    van Akkooi AC; Bouwhuis MG; de Wilt JH; Kliffen M; Schmitz PI; Eggermont AM
    Br J Surg; 2007 Oct; 94(10):1293-9. PubMed ID: 17702089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognosis after sentinel node biopsy in malignant melanoma].
    Lock-Andersen J; Horn J; Sjøstrand H
    Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node biopsy in patients with Stage I/II melanoma: Clinical experience and literature review.
    Gipponi M; Di Somma C; Peressini A; Solari N; Gliori S; Nicolo G; Schenone F; Queirolo P; Sertoli MR; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):133-40. PubMed ID: 14991885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymphadenectomy for cutaneous melanoma: who, what, and why.
    Bower M; Scoggins CR
    J Ky Med Assoc; 2009 Jul; 107(7):253-8. PubMed ID: 19678500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States.
    Bilimoria KY; Balch CM; Bentrem DJ; Talamonti MS; Ko CY; Lange JR; Winchester DP; Wayne JD
    Ann Surg Oncol; 2008 Jun; 15(6):1566-76. PubMed ID: 18414952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete lymph node dissection for regional nodal metastasis.
    Dzwierzynski WW
    Clin Plast Surg; 2010 Jan; 37(1):113-25. PubMed ID: 19914463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology of melanocytic lesions: new, controversial, and clinically important issues.
    Scolyer RA; Thompson JF; Stretch JR; Sharma R; McCarthy SW
    J Surg Oncol; 2004 Jul; 86(4):200-11. PubMed ID: 15221927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional lymph node dissections in malignant melanoma.
    Lawton GP; Ariyan S
    Clin Plast Surg; 2000 Jul; 27(3):431-40, ix. PubMed ID: 10941563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection.
    van der Ploeg AP; van Akkooi AC; Rutkowski P; Cook M; Nieweg OE; Rossi CR; Testori A; Suciu S; Verhoef C; Eggermont AM;
    Br J Surg; 2012 Oct; 99(10):1396-405. PubMed ID: 22961519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical therapy of malignant melanoma of the skin].
    Bachter D
    Praxis (Bern 1994); 2001 Feb; 90(8):307-13. PubMed ID: 11256333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node biopsy in melanoma patients: the medical oncologist's perspective.
    Queirolo P; Taveggia P; Gipponi M; Sertoli MR
    J Surg Oncol; 2004 Mar; 85(3):162-5. PubMed ID: 14991888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node biopsy from the vantage point of an oncologic surgeon.
    Wilson LL
    Clin Dermatol; 2009; 27(6):594-6. PubMed ID: 19880046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study.
    Wong SL; Morton DL; Thompson JF; Gershenwald JE; Leong SP; Reintgen DS; Gutman H; Sabel MS; Carlson GW; McMasters KM; Tyler DS; Goydos JS; Eggermont AM; Nieweg OE; Cosimi AB; Riker AI; G Coit D
    Ann Surg Oncol; 2006 Jun; 13(6):809-16. PubMed ID: 16604476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.